personalised medicine

Digital

Trust and treatment: GenAI in life sciences in 2024

In 2023, the life sciences industry was rocked by generative artificial intelligence. This year, we'll see some of these ideas become reality.

Patients

How to leverage real-world data for better patient care

Real-world data (RWD) creates exciting new opportunities to improve patient safety.

Oncology

ASCO 2023 – Arun Krishna

With a 51% reduction in deaths, AstraZeneca’s ADAURA trial was one of the breakout stories of this year’s ASCO.

Views & Analysis

At ESMO 2022, oncologists saw exciting cancer advances

Lung, breast, and non-prostate genitourinary (NGU) cancer treatments were the most exciting tracks due to the march towards personalised medicine and expanded immunotherapy options.

News

Merck gets on board with Moderna cancer vaccine in $250m dea...

Shares in Moderna were ticking upwards today after Merck & Co took up an option on a personalised RNA-based cancer vaccine with a payment of $250 million.

Views & Analysis

The NIH on accelerating research using diverse biomedical da...

Martin Mendoza, PhD, director of health equity and health science policy for the All of Us Research Program at the National Institutes of Health (NIH), tells pharmaphorum about the